ATE322508T1 - Verwendung des antikörpers 271.14d9.f8 (dsm acc2331) um die bindung zwischen alphavbeta6- integrin und fibronectin in vitro zu hemmen - Google Patents
Verwendung des antikörpers 271.14d9.f8 (dsm acc2331) um die bindung zwischen alphavbeta6- integrin und fibronectin in vitro zu hemmenInfo
- Publication number
- ATE322508T1 ATE322508T1 AT99907361T AT99907361T ATE322508T1 AT E322508 T1 ATE322508 T1 AT E322508T1 AT 99907361 T AT99907361 T AT 99907361T AT 99907361 T AT99907361 T AT 99907361T AT E322508 T1 ATE322508 T1 AT E322508T1
- Authority
- AT
- Austria
- Prior art keywords
- integrin
- fibronectin
- vitro
- antibody
- inhibit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2848—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98101108 | 1998-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE322508T1 true ATE322508T1 (de) | 2006-04-15 |
Family
ID=8231295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99907361T ATE322508T1 (de) | 1998-01-23 | 1999-01-11 | Verwendung des antikörpers 271.14d9.f8 (dsm acc2331) um die bindung zwischen alphavbeta6- integrin und fibronectin in vitro zu hemmen |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1049718B1 (de) |
| JP (1) | JP2002501086A (de) |
| KR (1) | KR20010034327A (de) |
| CN (1) | CN1168741C (de) |
| AR (1) | AR014464A1 (de) |
| AT (1) | ATE322508T1 (de) |
| AU (1) | AU2716399A (de) |
| BR (1) | BR9907218A (de) |
| CA (1) | CA2319160A1 (de) |
| DE (1) | DE69930723T2 (de) |
| HU (1) | HUP0101151A3 (de) |
| ID (1) | ID27810A (de) |
| NO (1) | NO20003767L (de) |
| PL (1) | PL341569A1 (de) |
| SK (1) | SK10772000A3 (de) |
| WO (1) | WO1999037683A1 (de) |
| ZA (1) | ZA99453B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1176195B1 (de) | 1999-04-09 | 2013-05-22 | Kyowa Hakko Kirin Co., Ltd. | Verfahren zur kontrolle der aktivität von immunologisch funktionellem molekül |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| WO2002085405A2 (en) | 2001-04-24 | 2002-10-31 | Merck Patent Gmbh | COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF$g(a) |
| EP1414491A4 (de) | 2001-07-09 | 2005-07-06 | Elan Pharm Inc | Verfahren zur hemmung der toxizität von amyloid |
| US7829087B2 (en) | 2001-07-09 | 2010-11-09 | Elan Pharmaceuticals, Inc. | Methods of treating cognitive impairment |
| CN1646160A (zh) | 2002-03-13 | 2005-07-27 | 拜奥根Idec马萨诸塞公司 | 抗αvβ6抗体 |
| CN102875681A (zh) * | 2005-07-08 | 2013-01-16 | 拜奥根Idec马萨诸塞公司 | 抗-αvβ6抗体及其用途 |
| AU2007207465B2 (en) | 2006-01-18 | 2012-12-06 | Merck Patent Gmbh | Specific therapy using integrin ligands for treating cancer |
| HRP20150884T1 (hr) | 2006-03-21 | 2015-09-25 | Genentech, Inc. | Kombinacijska terapija koja ukljuäśuje antagoniste alfa5beta1 |
| CN101563105B (zh) | 2006-07-10 | 2013-01-23 | 拜奥根Idec马萨诸塞公司 | 用于抑制smad4-缺陷癌症的组合物和方法 |
| TW200815474A (en) | 2006-08-03 | 2008-04-01 | Astrazeneca Ab | Antibodies alphaVbeta6 and uses thereof |
| CN101588812A (zh) | 2007-01-18 | 2009-11-25 | 默克专利有限公司 | 使用整联蛋白配体治疗癌的特异疗法和药物 |
| CL2008002856A1 (es) | 2007-09-26 | 2009-01-16 | Genentech Inc | Anticuerpo novedoso (anticuerpo anti-integrina a5b1; mol}ecula de ácido nucleico que lo codifica; vector y célula huesped; método de producción; composición farmacéutica que lo comprende; su uso para inhibir la angiogénesis y/o permeabilidad vascular y cáncer entre otras patologías; y método de detección de la integrina a5b1). |
| ES2457822T3 (es) | 2007-11-08 | 2014-04-29 | The General Hospital Corporation | Procedimientos y composiciones de tratamiento de enfermedades proteinúricas |
| MY173526A (en) | 2009-03-25 | 2020-01-31 | Genentech Inc | Novel anti-?5?1 antibodies and uses thereof |
| NZ597339A (en) | 2009-05-25 | 2013-10-25 | Merck Patent Gmbh | Continuous administration of cilengitide in cancer treatments |
| MX342270B (es) * | 2010-02-18 | 2016-09-21 | The Regents Of The Univ Of California * | ANTICUERPO NEUTRALIZANTE DE LA INTEGRINA AVß8. |
| WO2014143739A2 (en) | 2013-03-15 | 2014-09-18 | Biogen Idec Ma Inc. | Anti-alpha v beta 6 antibodies and uses thereof |
| US10035859B2 (en) | 2013-03-15 | 2018-07-31 | Biogen Ma Inc. | Anti-alpha V beta 6 antibodies and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69531187T2 (de) * | 1994-12-20 | 2004-04-22 | Merck Patent Gmbh | Monoklonaler Antikörper gegen das Alpha-V-Integrin |
-
1999
- 1999-01-11 AT AT99907361T patent/ATE322508T1/de not_active IP Right Cessation
- 1999-01-11 KR KR1020007008052A patent/KR20010034327A/ko not_active Withdrawn
- 1999-01-11 AU AU27163/99A patent/AU2716399A/en not_active Abandoned
- 1999-01-11 SK SK1077-2000A patent/SK10772000A3/sk unknown
- 1999-01-11 JP JP2000528603A patent/JP2002501086A/ja active Pending
- 1999-01-11 DE DE69930723T patent/DE69930723T2/de not_active Expired - Lifetime
- 1999-01-11 BR BR9907218-1A patent/BR9907218A/pt not_active IP Right Cessation
- 1999-01-11 CA CA002319160A patent/CA2319160A1/en not_active Abandoned
- 1999-01-11 PL PL99341569A patent/PL341569A1/xx unknown
- 1999-01-11 CN CNB998022829A patent/CN1168741C/zh not_active Expired - Fee Related
- 1999-01-11 WO PCT/EP1999/000101 patent/WO1999037683A1/de not_active Ceased
- 1999-01-11 HU HU0101151A patent/HUP0101151A3/hu unknown
- 1999-01-11 EP EP99907361A patent/EP1049718B1/de not_active Expired - Lifetime
- 1999-01-11 ID IDW20001566A patent/ID27810A/id unknown
- 1999-01-21 ZA ZA9900453A patent/ZA99453B/xx unknown
- 1999-01-22 AR ARP990100258A patent/AR014464A1/es not_active Application Discontinuation
-
2000
- 2000-07-21 NO NO20003767A patent/NO20003767L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2319160A1 (en) | 1999-07-29 |
| KR20010034327A (ko) | 2001-04-25 |
| BR9907218A (pt) | 2000-10-24 |
| WO1999037683A1 (de) | 1999-07-29 |
| ID27810A (id) | 2001-04-26 |
| CN1168741C (zh) | 2004-09-29 |
| SK10772000A3 (sk) | 2001-01-18 |
| JP2002501086A (ja) | 2002-01-15 |
| PL341569A1 (en) | 2001-04-23 |
| EP1049718B1 (de) | 2006-04-05 |
| HUP0101151A3 (en) | 2004-06-28 |
| HUP0101151A2 (hu) | 2001-08-28 |
| EP1049718A1 (de) | 2000-11-08 |
| ZA99453B (en) | 1999-07-21 |
| DE69930723T2 (de) | 2006-11-16 |
| NO20003767D0 (no) | 2000-07-21 |
| NO20003767L (no) | 2000-07-21 |
| AR014464A1 (es) | 2001-02-28 |
| DE69930723D1 (de) | 2006-05-18 |
| AU2716399A (en) | 1999-08-09 |
| CN1288469A (zh) | 2001-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE322508T1 (de) | Verwendung des antikörpers 271.14d9.f8 (dsm acc2331) um die bindung zwischen alphavbeta6- integrin und fibronectin in vitro zu hemmen | |
| IL142917A0 (en) | Substituted 2-phenylbenzimidazoles, the production thereof and their use | |
| HRP20120132A8 (hr) | Azabicikloalkani u svojstvu modulatora ccr5 | |
| EE200100437A (et) | C-21 modifitseeritud epotioloonid, nende valmistamise meetod ning kasutamine | |
| HUP0302128A3 (en) | Anti-dual integrin antibodies, compositions, methods and uses | |
| IL143102A0 (en) | 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof | |
| DE59709806D1 (de) | Cycloolefincopolymere, ihre verwendung und daraus hergestellte formkörper | |
| DE69814431D1 (de) | 3,3-diarylpropylamine , ihre verwendung und herstellung | |
| DE69709315D1 (de) | Weichmacherlotionzusammensetzung, ihre verwendung in der papierherstellung und papierprodukt | |
| ATE272634T1 (de) | Benzothiophenderivate, verhahren zu ihrer herstellung und ihre verwendung | |
| ZA200202816B (en) | Modified plant viruses and methods of use thereof. | |
| HUP0101624A3 (en) | New substituted amides, their production and their use | |
| AU2608602A (en) | Silensed anti-cd28 antibodies and use thereof | |
| GB9927332D0 (en) | Novel antibody and uses thereof | |
| DE69801818D1 (de) | Metallkomplex-Disazofarbstoffe, ihre Herstellung und Verwendung | |
| ATE335000T1 (de) | Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung | |
| HUP0101475A3 (en) | 4,5,6 and 7-indole and indoline derivatives, their preparation and use | |
| DK1138677T3 (da) | Fremgangsmåde til fremstilling af 11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepin og anvendelse til syntese af tianeptin | |
| DE69829523D1 (de) | Reissverschluss und Verpackung zu seiner Verwendung | |
| IT1294441B1 (it) | Impianto per il colaggio in pressione di articoli sanitari | |
| DE69838646D1 (de) | Isolierte decapeptide, die an hla moleküle binden, sowie deren verwendung | |
| IL136296A0 (en) | Catalyst, process for its preparation, and its use in the synthesis of 1,2-dichloroethane | |
| ITRM950316A0 (it) | Materiale in lega per tissofusione, procedimento per la preparazione del materiale in lega semi-fuso per tissofusione e procedimento di tissofusione. | |
| ATE485271T1 (de) | Antihistaminische piperidinderivate und zwischenprodukte zu ihrer herstellung | |
| EG22778A (en) | Substituted n-benzoyl-n'-(tetrazolylphenyl)-ureas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |